Stock Overview

Norris Medicines Share Price

Norris Medicines Share Price

15.5
-0.50 (-3.13%)
28 Jul, 2026 • 03:30 PM
BSE: 524414 | Pharmaceuticals | Small Cap

Norris Medicines Annualised Returns

1 Year

-2.21%Decrease

3 Years

11.56%Increase

5 Years

15.71%Increase

Norris Medicines Share Price Today


As of 28 Jul 2026, Norris Medicines share price is ₹15.5. The stock opened at ₹15.5 and had closed at ₹16 the previous day. During today’s trading session, Norris Medicines share price moved between ₹15.20 and ₹16.00, with an average price for the day of ₹15.60. Over the last 52 weeks, the stock has recorded a low of ₹12.00 and a high of ₹19.63. In terms of performance, Norris Medicines share price has increased by 19.2% over the past six months and has declined by 2.21% over the last year.

Norris Medicines Stock Performance

1W Return-0.32%
1M Return14.48%
6M Return19.23%
1Y Return-7.46%
3Y Return30.58%
Today's High₹16
Today's Low₹15.2
52-Week High₹19.63
52-Week Low₹12
Prev. Close₹16.00
Open₹15.50
Face Value₹10
Mkt Cap (Cr.)₹16
PE Ratio-57.14

Norris Medicines Share Price Chart

Norris Medicines Company background

Founded in: 1990
Managing director: Vimal D Shah
Norris Medicines Limited was established in September, 1990 as a small scale unit at GIDC Estate, Ankleshwar to manufacture non sterile dosage e.g. tablets, capsules, Liquid Orals, Copical ointments. The Company was subsequently converted into Public Limited Company on March 7, 1992. The unit expanded to manufacture Sterile dosage in form of Ampoules Vials. The Company got into the business in the year 1990. Commercial production of the formulation unit commenced in Nov.91. The production unit expanded to manufacture Sterile dosage in form of Ampoules Vials. The project commence in March 1992. Thereafter, the Company came out with a Public Issue aggregating Rs. 5 Crore in December, 1993 to expand its existing capacity for tablets, capsules, etc, besides diversifying into bulk drugs and setting up an injectables unit. The project costing Rs 14.21 Crore was financed through loans and equity, which got completed in 1995.In 2006, the Company launched Diabetic Cardiac products launched Dental product in 2007 launched New Molecule Tolperisone with Paracetamol tablet in 2012 in 2013, it extended Anti malarial range with Artemether Lumefantrine tablet dry syrup. During the year 201314, the Company undertook the upgradation of Sterile Injectable Plant. The Company is one of the leading Indian manufacturers of Injections and Medicinal formulations. The Company is engaged into Health Care Industry and operate 2 plants situated at GIDC, Ankleshwar, Gujarat. Both plants of the Company are WHO GMP approved. At present, it has renovated the Sterile Injectable Plant and with this the plant is now as per international standards.
Norris Medicines SIP Returns Calculator
5,000
Over the past
Total Investment of ₹3,00,000
Monthly SIP of 5,000 would have become 4,57,477 in 5 years with a gain of 1,57,477 (+52.49%)

Norris Medicines Fundamental

Market Cap (in crs)

16.00

Face Value

10

Turnover (in lacs)

0.06

Key Metrics

Qtr Change %
29.17% Gain from 52W Low
Dividend yield 1yr %
0

Norris Medicines Technical Analysis

Moving Averages Analysis
15.5
Current Price
Bullish Moving Averages
11
Bearish Moving Averages
5
Use arrow keys to navigate between tabs, Enter or Space to select, Home and End to go to first or last tab.
5 EMA
16.00
10 EMA
16.10
12 EMA
16.10
20 EMA
15.90
26 EMA
15.70
50 EMA
15.20
100 EMA
14.80
200 EMA
15.10
Delivery & Volume
Loading chart...

Day

98.80%

Week

99.50%

Month

92.30%

Delivery & Volume

15.73
Pivot
Resistance
First Resistance
16.27
Second Resistance
16.53
Third Resistance
17.07
Support
First Support
15.47
Second support
14.93
Third Support
14.67
Relative Strength Index
52.20
Money Flow Index
58.10
MACD
0.37
MACD Signal
0.55
Average True Range
1.16
Average Directional Index
25.59
Rate of Change (21)
18.17
Rate of Change (125)
24.32
Compare

Norris Medicines Shareholding Pattern

Use arrow keys to navigate between tabs, Enter or Space to select, Home and End to go to first or last tab.
Promoter
34%
Domestic Institutions
0.1%
Public
65.9%

Norris Medicines Latest News

03 JUL 2026
24 JUN 2026
30 MAY 2026

The Mutual Fund Shareholding in Norris Medicines was 0.01% at the end of 28/7/2026.

You can easily buy Norris Medicines shares in Kotak Neo by opening a demat account and getting the KYC documents verified online.

The 52-week high and low of Norris Medicines share price is ₹19.63 and ₹12 as of 28/7/2026.

Please be aware that Norris Medicines stock prices are subject to continuous fluctuations due to various factors.